{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:24:06Z","timestamp":1758925446036},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.leukres.2004.06.009","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:27:57Z","timestamp":1095186477000},"page":"205-213","source":"Crossref","is-referenced-by-count":14,"title":["Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Sara","family":"Ek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl A.K.","family":"Borrebaeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2004.06.009_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00125480-199811000-00011","article-title":"Mantle cell lymphoma","volume":"5","author":"Kurtin","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.leukres.2004.06.009_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/hupa.2002.30221","article-title":"From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades","volume":"33","author":"Swerdlow","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.leukres.2004.06.009_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0145-2126(02)00026-7","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma","volume":"26","author":"Drexler","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.06.009_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.leukres.2004.06.009_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2141.2003.04438.x","article-title":"Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells","volume":"122","author":"Bogner","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2004.06.009_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.06.009_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(02)00823-3","article-title":"Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model","volume":"143","author":"M\u2019Kacher","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2004.06.009_bib8","first-page":"4398","article-title":"Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells","volume":"62","author":"Ek","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.06.009_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma","volume":"68","author":"Thorselius","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2004.06.009_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL, defined by the use of specific VH genes and the frequency of somatic mutations","author":"Camacho","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0145-2126(99)00156-3","article-title":"Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation","volume":"24","author":"Laszlo","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2004.06.009_bib12","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1046\/j.1365-2141.1998.00907.x","article-title":"Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes","volume":"102","author":"Pittaluga","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2004.06.009_bib14","first-page":"1629","article-title":"Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma","volume":"61","author":"Welzel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.06.009_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2400555","article-title":"Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)","volume":"11","author":"Jadayel","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2004.06.009_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5","article-title":"The establishment of Epstein-Barr virus nuclear antigen-positive (SP- 50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma","volume":"64","author":"Daibata","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2004.06.009_bib17","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood.V72.6.2026.2026","article-title":"Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)]","volume":"72","author":"Saltman","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10428199809059223","article-title":"History and classification of human leukemia-lymphoma cell lines","volume":"31","author":"Drexler","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2004.06.009_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/82.6.501","article-title":"Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines","volume":"82","author":"Beckwith","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2004.06.009_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0950-3536(97)80024-8","article-title":"Normal human B cell sub-populations and their malignant counterparts","volume":"10","author":"Pascual","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.leukres.2004.06.009_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ng0193-88","article-title":"Structure and physical map of 64 variable segments in the 3\u20320.8-megabase region of the human immunoglobulin heavy-chain locus","volume":"3","author":"Matsuda","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2004.06.009_bib22","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","article-title":"Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma","volume":"101","author":"Walsh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/nar\/27.1.209","article-title":"IMGT, the international ImMunoGeneTics database","volume":"27","author":"Lefranc","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.leukres.2004.06.009_bib24","unstructured":"Ek S, Bjorck E, Hogerkor C-M, Walsh SH, Thorselius M, Rosenquist R, et al. Mantle cell lymphomas overexpress CCL4, CCL5 and 4-1BB ligand and show evidence of an activated B cell origin. Manuscript submitted."},{"key":"10.1016\/j.leukres.2004.06.009_bib25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.180.1.329","article-title":"Analysis of somatic mutation in five B cell subsets of human tonsil","volume":"180","author":"Pascual","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2004.06.009_bib27","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1182\/blood.V99.6.1913","article-title":"BCR ligation reprograms B cells for migration to the T zone and B-cell follicle sequentially","volume":"99","author":"Casamayor-Palleja","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/416094a","article-title":"Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position","volume":"416","author":"Reif","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2004.06.009_bib29","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","article-title":"Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells","volume":"162","author":"Krzysiek","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.06.009_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1399-0039.2000.560201.x","article-title":"Platelet endothelial cell adhesion molecule-1 (PECAM-1\/CD31) is associated with a naive B-cell phenotype in human tonsils","volume":"56","author":"Jackson","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.leukres.2004.06.009_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.160.1.395","article-title":"Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member","volume":"160","author":"Deaglio","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.06.009_bib32","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4049\/jimmunol.166.4.2228","article-title":"Signals that initiate somatic hypermutation of B cells in vitro","volume":"166","author":"Bergthorsdottir","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.06.009_bib33","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V97.6.1892","article-title":"CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia","volume":"97","author":"Thunberg","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.06.009_bib34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1096\/fasebj.10.12.8903511","article-title":"Human CD38, a cell-surface protein with multiple functions","volume":"10","author":"Mehta","year":"1996","journal-title":"Faseb J"},{"key":"10.1016\/j.leukres.2004.06.009_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line","volume":"26","author":"Lai","year":"2002","journal-title":"Mino Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T09:27:47Z","timestamp":1682760467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0145212604002395"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.06.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}